Environmental Factors and Their Regulation of Immunity in Multiple Sclerosis
暂无分享,去创建一个
[1] R. Liblau,et al. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis , 2011, FEBS letters.
[2] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[3] L. Blizzard,et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[4] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[5] D. Halbert,et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. , 2002, Cellular immunology.
[6] Pierre Grammond,et al. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis , 2012, PloS one.
[7] A. Mildner,et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes , 2007, Nature Genetics.
[8] Tsung-Cheng Chang,et al. microRNAs in vertebrate physiology and human disease. , 2007, Annual review of genomics and human genetics (Print).
[9] M. Ramanathan,et al. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis , 2009, Neurology.
[10] N. Rajewsky,et al. Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.
[11] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Krumbholz,et al. Humoral autoimmunity in multiple sclerosis , 2011, Journal of the Neurological Sciences.
[13] P. Rieckmann,et al. The natural history of primary progressive multiple sclerosis , 2009, Neurology.
[14] A. Kessels,et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis , 2008, Multiple sclerosis.
[15] Eman N. Ali,et al. Smoking and disease progression in multiple sclerosis. , 2009, Archives of neurology.
[16] E. Coccia,et al. Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation , 2010, Journal of neuropathology and experimental neurology.
[17] J. Pers,et al. Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.
[18] J. Mendell,et al. MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.
[19] Lorraine Lau,et al. MMPs in the central nervous system: where the good guys go bad. , 2008, Seminars in cell & developmental biology.
[20] Arne Svejgaard,et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.
[21] D. Foureau,et al. Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.
[22] E. Granieri,et al. Incidence of multiple sclerosis in Macomer, Sardinia, 1912–1981 , 1986, Neurology.
[23] A. Ascherio,et al. Vitamin D and multiple sclerosis , 2010, The Lancet Neurology.
[24] A. Noor,et al. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated , 2007, Journal of neuroscience research.
[25] F. Barkhof,et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial , 2011, The Lancet.
[26] A. Sadovnick,et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[27] F. Mastronardi,et al. The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.
[28] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[29] Mathew B. Cox,et al. MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood , 2010, PloS one.
[30] G. Pantaleo,et al. HLA-B7–Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis , 2012, The Journal of Immunology.
[31] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[32] M. Hernán,et al. Cigarette smoking and the progression of multiple sclerosis. , 2005, Brain : a journal of neurology.
[33] I. Adcock,et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] G. Teng,et al. Shhh! Silencing by microRNA-155 , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[35] L. Wilkins. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.
[36] R. Reynolds,et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.
[37] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[38] V. Yong,et al. Environmental factors and their regulation of immunity in multiple sclerosis , 2012, Journal of the Neurological Sciences.
[39] T. Gant,et al. Smoking induces differential miRNA expression in human spermatozoa: A potential transgenerational epigenetic concern? , 2012, Epigenetics.
[40] B. Trapp,et al. Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.
[41] T. Olsson,et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.
[42] A. Bird,et al. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.
[43] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[44] M. Pender. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis , 2012, Autoimmune diseases.
[45] M. Campbell,et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. , 2011, Human molecular genetics.
[46] Emily Bernstein,et al. RNA meets chromatin. , 2005, Genes & development.
[47] J. Antel,et al. Myelin basic protein and human coronavirus 229E cross‐reactive T cells in multiple sclerosis , 1996, Annals of neurology.
[48] Ryan M. O’Connell,et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. , 2010, Immunity.
[49] C. Ackerley,et al. Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.
[50] J. Lünemann,et al. Viral triggers of multiple sclerosis , 2010, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[51] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.
[52] K. Berer,et al. Remote control-triggering of brain autoimmune disease in the gut. , 2013, Current opinion in immunology.
[53] A. M. Walker,et al. Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology. , 1980, Journal of epidemiology and community health.
[54] B. Becher,et al. T(H)17 cytokines in autoimmune neuro-inflammation. , 2011, Current opinion in immunology.
[55] Thomas Tuschl,et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.
[56] J. Minárovits,et al. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. , 2009, Seminars in cancer biology.
[57] L. Nagy,et al. 1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype12 , 2009, The Journal of Immunology.
[58] A. Bergamini,et al. 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. , 2009, Cytokine.
[59] R. Coletta,et al. Impact of smoking on inflammation: overview of molecular mechanisms , 2011, Inflammation Research.
[60] J. Correale,et al. Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.
[61] T. Kuhlmann,et al. Changed Histone Acetylation Patterns in Normal-Appearing White Matter and Early Multiple Sclerosis Lesions , 2011, The Journal of Neuroscience.
[62] Wei Cheng,et al. Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. , 2012, Frontiers in bioscience.
[63] Antonio J. Berlanga-Taylor,et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis , 2011, Annals of neurology.
[64] P. Hart,et al. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? , 2011, Nature Reviews Immunology.
[65] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[66] A. Bird,et al. Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.
[67] V. Yong,et al. Predominance of Th2 polarization by Vitamin D through a STAT6-dependent mechanism , 2011, Journal of Neuroinflammation.
[68] H. Lassmann,et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. , 2009, Brain : a journal of neurology.
[69] M. Hernán,et al. Cigarette smoking and incidence of multiple sclerosis. , 2001, American journal of epidemiology.
[70] C. Martyn,et al. Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.
[71] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.
[72] D. Clayton,et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.
[73] Weiliang Qiu,et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. , 2012, Human molecular genetics.
[74] A. Lutterotti,et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis , 2008, Multiple sclerosis.
[75] M. Alter,et al. Risk of multiple sclerosis related to age at immigration to Israel. , 1966, Archives of neurology.
[76] N. Cerf-Bensussan,et al. The immune system and the gut microbiota: friends or foes? , 2010, Nature Reviews Immunology.
[77] L. Martin,et al. Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.
[78] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[79] Mary T. Brinkoetter,et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Nature Medicine.
[80] Jiuhong Kang,et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.
[81] P. Joensen. Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands , 2011, Multiple sclerosis.
[82] O. Griesbeck,et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. , 2010, Immunity.
[83] T. Yamamura,et al. Immunopathology and Infectious Diseases NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora , 2010 .
[84] Sneha S. Joshi,et al. 1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.
[85] A. Ivanov,et al. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross‐react with myelin basic protein and EBV antigen , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[86] Luanne M. Metz,et al. Epigenetic changes in patients with multiple sclerosis , 2013, Nature Reviews Neurology.
[87] K. Berer,et al. Microbial view of central nervous system autoimmunity , 2014, FEBS letters.
[88] J M Lemire,et al. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.
[89] S. Patten,et al. A Quantitative Analysis of Suspected Environmental Causes of MS , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[90] H. Weiner,et al. Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.
[91] F. Roman,et al. Developmental vitamin D deficiency alters learning in C57Bl/6J mice , 2010, Behavioural Brain Research.
[92] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[93] M. Fabbri,et al. Regulatory mechanisms of microRNAs involvement in cancer , 2007, Expert opinion on biological therapy.
[94] D. Bourdette,et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis , 2008, Current neurology and neuroscience reports.
[95] K. Berer,et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.
[96] S. Miller,et al. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease , 2011, Immunological reviews.
[97] T. Köse,et al. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. , 2011, Oral diseases.
[98] J. Knight,et al. Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.
[99] Michael Weber,et al. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. , 2007, Current Opinion in Cell Biology.
[100] R. Knight,et al. The Human Microbiome Project , 2007, Nature.
[101] T. Holmøy,et al. Vitamin D in the healthy and inflamed central nervous system: access and function , 2011, Journal of the Neurological Sciences.
[102] T. Dwyer,et al. Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.
[103] S. Muller,et al. Epigenetic Histone Code and Autoimmunity , 2010, Clinical reviews in allergy & immunology.
[104] K. Berer,et al. Commensal gut flora and brain autoimmunity: a love or hate affair? , 2012, Acta Neuropathologica.
[105] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[106] Philip W. Landfield,et al. Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.
[107] T. Dwyer,et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis , 2009, Journal of Neurology.
[108] George A. Calin,et al. Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.
[109] M. Campbell,et al. Vitamin D has wide regulatory effects on histone demethylase genes , 2012, Cell cycle.
[110] S. Mazmanian,et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[111] Michael K. Skinner,et al. Epigenetic transgenerational actions of environmental factors in disease etiology , 2010, Trends in Endocrinology & Metabolism.
[112] A. Bar-Or,et al. B cells in multiple sclerosis: connecting the dots. , 2011, Current opinion in immunology.